Funded Tech Companies
Convergen
Convergen, operating out of Suzhou, received equity investments from Matrix Partners, LAV Fund and BioTrack Capital.
Company Overview
Company Name
Convergen
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Convergen is a biotech company pioneering TrimTAC--next-generation bifunctional degraders that leverage TRIM21 to selectively clear pathological multimeric proteins. Founded to address unmet medical needs in neurodegenerative disease and beyond, the company combines cutting-edge academic research with industry-proven drug development expertise to advance therapies for significantly unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/31/2026
Financing History
Management Team
Title
Name
Email & Social
Co-Founder
Ting Han
Co-Founder
Jinquan Sun
Company Investors
Browse more funded tech companies:
Converged Access | Convergence
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs